A new book to be released this week chronicles the recent history and potentially troubling future for the pharmaceutical industry. Pharmaplasia describes in detail how Big Pharma grew too fast, creating organizations that were too large to manage effectively and efficiently.
The author is an industry veteran, Mike Wokasch, whose career includes tenures at Merck, Covance, Abbott, Bayer, Chiron, and Vertex. A revealing insider’s perspective, Pharmaplasia is an informative and thought provoking read for past and present industry executives and for anyone who wonders why their drugs cost so much, why patients don’t have the drugs they might need, and where this industry is headed.
No one really knows how history will remember this turbulent time as the pharmaceutical industry painfully reinvents itself. Yet publications like this should begin to tell the whole story and begin to form a perspective of just how dramatic the change will be.
